Our Products
MOXYMUL CV 625
Product Composition
Packaging Details
Product Description
Moxymul-CV 625 – Amoxicillin 500 mg + Clavulanic Acid 125 mg Tablets
Moxymul-CV 625 by Amcare Pharmaceuticals is a prescription antibacterial combination containing Amoxicillin Trihydrate IP equivalent to Amoxicillin 500 mg and Diluted Potassium Clavulanate IP equivalent to Clavulanic Acid 125 mg per film-coated tablet.
Moxymul-CV 625 Composition
Each film-coated tablet contains:
- Amoxicillin Trihydrate IP equivalent to Amoxicillin – 500 mg
- Diluted Potassium Clavulanate IP equivalent to Clavulanic Acid – 125 mg
- Excipients – q.s.
Moxymul-CV 625 Product Details
| Parameter | Details |
|---|---|
| Brand Name | Moxymul-CV 625 |
| Generic Name | Amoxicillin + Clavulanic Acid |
| Strength | 500 mg + 125 mg |
| Dosage Form | Film-Coated Tablet |
| Route | Oral |
| Category | Prescription Antibacterial |
| Pack Size | 10 × 10 Tablets |
| Company | Amcare Pharmaceuticals |
Moxymul-CV 625 Uses
Moxymul-CV 625 may be prescribed for susceptible bacterial infections, including certain lower respiratory tract infections, acute bacterial ear infections, sinusitis, skin and skin-structure infections, and urinary tract infections.
It should be used only when a bacterial infection is proven or strongly suspected. It is not intended for viral infections such as the common cold or influenza.
Moxymul-CV 625 Benefits
- Contains Amoxicillin 500 mg + Clavulanic Acid 125 mg
- Combines a penicillin-class antibacterial with a beta-lactamase inhibitor
- Film-coated tablet formulation
- Convenient oral dosage form
- Available in a 10 × 10 tablet pack
How Does Moxymul-CV 625 Work?
Amoxicillin in Moxymul-CV 625
Amoxicillin is a penicillin-class antibacterial that interferes with bacterial cell-wall synthesis, helping inhibit the growth of susceptible bacteria.
Clavulanic Acid in Moxymul-CV 625
Clavulanic acid is a beta-lactamase inhibitor. It helps inhibit certain beta-lactamase enzymes that can otherwise reduce the antibacterial activity of amoxicillin.
Moxymul-CV 625 Antibacterial Action
The combination of amoxicillin and clavulanic acid provides antibacterial activity against susceptible organisms, including certain beta-lactamase-producing bacteria.
Moxymul-CV 625 Dosage and Administration
The dosage and duration should be determined by the prescribing healthcare professional based on the infection, age, body weight, kidney function and clinical condition.
- Take exactly as prescribed.
- Take the medicine at the recommended intervals.
- Complete the prescribed course unless advised otherwise by your doctor.
- Do not self-medicate with antibiotics.
- Patients with kidney impairment may require dose adjustment.
Moxymul-CV 625 Side Effects
Possible side effects may include:
- Diarrhea
- Nausea
- Vomiting
- Abdominal discomfort
- Indigestion
- Skin rash
Serious allergic reactions and antibiotic-associated Clostridioides difficile diarrhea can occur and require medical attention. Amoxicillin/clavulanate products also carry warnings concerning hepatic dysfunction.
Moxymul-CV 625 Precautions and Warnings
Inform your healthcare professional if you:
- Have an allergy to amoxicillin, penicillin, cephalosporins or other beta-lactam antibiotics.
- Have previously experienced a serious allergic reaction to an antibiotic.
- Have liver or kidney problems.
- Have a history of antibiotic-associated diarrhea.
- Are taking other medicines.
- Are pregnant or breastfeeding.
Amoxicillin/clavulanate is contraindicated in patients with a history of serious hypersensitivity reactions to beta-lactam antibiotics and in certain patients with previous cholestatic jaundice/hepatic dysfunction associated with the product.
Moxymul-CV 625 Storage
- Store according to the instructions on the product packaging.
- Protect from excessive heat and moisture.
- Keep tablets in their original packaging.
- Keep out of reach of children.
Why Choose Moxymul-CV 625 by Amcare Pharmaceuticals?
Moxymul-CV 625 by Amcare Pharmaceuticals provides Amoxicillin 500 mg + Clavulanic Acid 125 mg in a convenient film-coated tablet formulation for prescription use.